Teprotumumab improves symptoms and quality of life in thyroid eye disease patients Dr. Kamal Kant Kohli11 Feb 2020 6:00 PM ISTLOS ANGELES -- Researchers at Cedars-Sinai and at other medical centers nationwide have found that minimally invasive insulin-like growth factor I...
Study closely links protein to age-related macular degeneration Dr. Kamal Kant Kohli10 Feb 2020 3:30 PM ISTUK: A new Study closely links Protein to age-related macular degeneration.A team from Universities of Manchester, Cardiff, London and Nijmegen, and...
Attention Ophthalmologists: Sightsavers India invites applications for India Fellowship Program 2020 Medical Dialogues Bureau10 Feb 2020 12:00 PM ISTYou can apply for the Sightsavers India Fellowship Program before April 30th 2020.
Viagra use linked to visual disturbances in new study Dr. Kamal Kant Kohli10 Feb 2020 11:45 AM ISTUse of Sidenifil with common brand Viagra has been liked to vision disturbances including light sensitivity and color vision impairment in a new...
Researchers develop Novel lenses that self moisturise to prevent dry eye disease Dr. Kamal Kant Kohli24 Jan 2020 9:45 AM ISTSmart contact lenses are the order of the day and these wearable devices that could accelerate vision beyond natural human capabilities. They are...
Researchers develop a novel test that can predict Glaucoma risk by analysing DNA Hina Zahid23 Jan 2020 11:49 AM ISTGlaucoma is a group of diseases that are characterized by progressive damage and degeneration of the optic nerve, causing gradual loss of vision.
US FDA approves Tepezza- first treatment for thyroid eye disease MD Bureau22 Jan 2020 10:32 AM ISTUS : The U.S. Food and Drug Administration (FDA) has given its nod to Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye...
Binocular treatment no better than patching for amblyopia Medha Baranwal20 Jan 2020 11:45 AM ISTUSA: Binocular treatments of amblyopia cannot be recommended as a replacement for standard treatments (including patching and optical treatment), a...
